Stocks and Investing Stocks and Investing
Thu, August 19, 2021
Wed, August 18, 2021

Matthew Harrison Maintained (TSHA) at Buy with Decreased Target to $39 on, Aug 18th, 2021


Published on 2024-10-27 17:41:57 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Buy with Decreased Target from $43 to $39 on, Aug 18th, 2021.

Matthew has made no other calls on TSHA in the last 4 months.



There are 7 other peers that have a rating on TSHA. Out of the 7 peers that are also analyzing TSHA, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with Matthew


  • Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Decreased Target to $60 on, Tuesday, August 17th, 2021
  • Gil Blum of "Needham" Initiated at Strong Buy and Held Target at $45 on, Friday, July 16th, 2021
  • Joon Lee of "Truist Securities" Initiated at Strong Buy and Held Target at $60 on, Thursday, June 24th, 2021
  • Yun Zhong of "BTIG" Initiated at Strong Buy and Held Target at $44 on, Tuesday, June 15th, 2021
  • Laura Chico of "Wedbush" Initiated at Buy and Held Target at $31 on, Wednesday, June 9th, 2021
  • Silvan Tuerkcan of "JMP Securities" Initiated at Buy and Held Target at $40 on, Tuesday, June 8th, 2021
  • Kristen Kluska of "Cantor Fitzgerald" Initiated at Buy and Held Target at $44 on, Wednesday, May 19th, 2021

Contributing Sources